Use of 5-fluorouracil, epirubicin and mitomycin C (FEM) as adjuvant therapy in node-positive, radically-resected gastric cancer patients: survey of a general hospital experience.
Saved in:
| Title: | Use of 5-fluorouracil, epirubicin and mitomycin C (FEM) as adjuvant therapy in node-positive, radically-resected gastric cancer patients: survey of a general hospital experience. |
|---|---|
| Authors: | Caffo O; Department of Medical Oncology, S. Chiara Hospital, Largo Medaglie D'Oro, 38100 Trento, Italy., Ambrosini G, Amichetti M, Brugnara S, Graiff C, Robbiati SF, Galligioni E |
| Source: | Oncology reports [Oncol Rep] 1998 Nov-Dec; Vol. 5 (6), pp. 1465-9. |
| Publication Type: | Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print Cited Medium: Print ISSN: 1021-335X (Print) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
